Want to see TSE:VXL full AI Analyst Report?

Vaxil Bio (VXL) Revenue

22 Followers

Vaxil Bio Revenue

Vaxil Bio had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Mar 31, 2026, Vaxil Bio had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

C$0

Employees

Market Cap

C$577.68K

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	―	―	―
Mar 31, 2025	―	―	―
Mar 31, 2024	―	―	―
Mar 31, 2023	―	―	―
Mar 31, 2022	―	―	―
Mar 31, 2021	―	―	―
Mar 31, 2020	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―